Meat Derivative and Satiating Compound Effect on Satiety
NCT04088812 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 19
Last updated 2020-03-04
Summary
The purpose of this study is to evaluate the satiating effects of a meat derivative and a satiating compound on overweight subjects (BMI ≥25 and \<30 kg / m2).
Conditions
Interventions
- OTHER
-
Placebo meat derivative + Placebo satiating compound
Subjects will consume 60 g of meat derivative placebo in a brunch type meal with 25 g of the satiating compound placebo diluted in water
- OTHER
-
Placebo meat derivative + Satiating compound
Subjects will consume 60 g of meat derivative placebo in a brunch type meal with 25 g of the satiating compound diluted in water
- OTHER
-
Experimental meat derivative + Placebo satiating control
Subjects will consume 60 g of the experimental meat derivative in a brunch type meal with 25 g of satiating compound placebo diluted in water
Sponsors & Collaborators
-
Creaciones Aromáticas Industriales, S.A. (CARINSA)
collaborator UNKNOWN -
Instituto de Investigación Hospital Universitario La Paz
lead OTHER
Principal Investigators
-
Bricia López Plaza, PhD · La Paz University Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-10-11
- Primary Completion
- 2019-10-31
- Completion
- 2020-01-25
Countries
- Spain
Study Locations
More Related Trials
-
Intragastric Injections of Botox for the Treatment of Obesity
NCT02035397 ·Status: UNKNOWN ·Phase: PHASE2
-
A Research Study Investigating NNC0247-0829 for Weight Management in People With Overweight or Obesity
NCT04010786 ·Status: COMPLETED ·Phase: PHASE1
-
Acute Effects of SATIOSTAT Ingestion on Satiation Hormones, Gastric Emptying, Subjective Feelings of Appetite and Energy Intake
NCT02956356 ·Status: COMPLETED ·Phase: NA
-
Effect of Orlistat in Body Composition
NCT00752726 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of ZT006 in Overweight and Obese Participants
NCT07230132 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Study to Investigate the Safety, Tolerability, Pharmacokinetic/Pharmacodynamic Characteristics, and Food Effect of HSG4112
NCT04732988 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of Litramine in Overweight and Obese Subjects
NCT01233349 ·Status: COMPLETED ·Phase: PHASE3
-
To Assess the Effect of Lorcaserin Hydrochloride on Energy Metabolism and Food Intake
NCT00829140 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of the Body Slimming Effect of TCI904
NCT05805488 ·Status: COMPLETED ·Phase: NA
-
GLP-1 Analogue Effects on Food Cues, Stress, Motivation for Highly Palatable Foods, and Weight
NCT04779697 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of IQP-AK-102 in Reducing Appetite
NCT02041754 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of 2-year Administration of CP-945,598 on Weight Loss Efficacy and Safety.
NCT00396448 ·Status: TERMINATED ·Phase: PHASE3
-
A Phase II Study to Evaluate the Efficacy and Safety of MT921 in Subjects With Moderate to Severe Submental Fat
NCT04144049 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Long-Acting GLP-1 (Glucagon-like Peptide-1) or Dual Incretin (GLP-1 and GIP [Glucose-dependent Insulinotropic Peptide]) Modulation on Gastric Motor Functions
NCT06801015 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
A Research Study on How NNC0487-0111 Works in People With Overweight or Obesity
NCT05369390 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of IQP- AK-102 in Reducing Body Weight
NCT01905956 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of a Dietary Supplement on Hormones Involved in Appetite Regulation in Overweight and Obese Adults
NCT07240246 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Study of the Blood Levels and Effects of ATL-962 on Fat Excretion in Obese Subjects
NCT00148382 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Toleration and Efficacy of CP-741,952 for the Treatment of Obesity
NCT00367783 ·Status: TERMINATED ·Phase: PHASE2
-
A 35 Day Study to Investigate the Effects of GSK1521498 on Bodyweight in Obese Subjects With Over-Eating Behaviours.
NCT01195792 ·Status: COMPLETED ·Phase: PHASE2
-
Investigation Of Weight Loss And Body Composition Changes After Dosing With Either Placebo Or One Of Two Active Drugs
NCT00494767 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Zenoctil in Reducing Body Weight
NCT01423617 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Measure Energy Expenditure and Food Intake in Participants With Obesity Using Tirzepatide
NCT04081337 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of ZT002 Injection in Participants With Overweight or Obesity
NCT06371326 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Tirzepatide in Overweight and Very Overweight Participants
NCT04311411 ·Status: COMPLETED ·Phase: PHASE1